New epilepsy drug cuts seizures in major trial

NCT ID NCT03083665

Completed Symptom relief Sponsor: UCB Biopharma SRL Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 05, 2026 · Updated 26 times

Summary

This study tested whether adding brivaracetam to existing epilepsy medications helps reduce partial seizures in adults aged 16 to 80. About 449 participants took either the drug or a placebo for 12 weeks. The main goals were to check safety and see if seizure frequency dropped. Results showed brivaracetam was safe and reduced seizures more than placebo.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Ep0083 101

Sapporo, Japan
Ep0083 102

Kagoshima, Japan
Ep0083 103

Sendai, Japan
Ep0083 104

Shizuoka, Japan
Ep0083 105

Nagakute, Japan
Ep0083 106

Niigata, Japan
Ep0083 108

Suita, Japan
Ep0083 109

Yamagata, Japan
Ep0083 110

Hiroshima, Japan
Ep0083 111

Hamamatsu, Japan
Ep0083 112

Kōshi, Japan
Ep0083 114

Saitama, Japan
Ep0083 115

Kokubunji, Japan
Ep0083 116

Asaka, Japan
Ep0083 117

Nara, Japan
Ep0083 118

Nagoya, Japan
Ep0083 120

Yokohama, Japan
Ep0083 121

Itami, Japan
Ep0083 122

Hachinohe, Japan
Ep0083 123

Kodaira, Japan
Ep0083 124

Kyoto, Japan
Ep0083 126

Bunkyō City, Japan
Ep0083 127

Bunkyō City, Japan
Ep0083 128

Kurume, Japan
Ep0083 129

Neyagawa, Japan
Ep0083 130

Ôsaka, Japan
Ep0083 131

Ōtsu, Japan
Ep0083 132

Kōriyama, Japan
Ep0083 133

Ushiku, Japan
Ep0083 136

Nagoya, Japan
Ep0083 137

Suita, Japan
Ep0083 138

Tsukuba, Japan
Ep0083 140

Kawasaki, Japan
Ep0083 141

Higashisonogi-gun Kawatana-cho, Japan
Ep0083 142

Kamakura, Japan
Ep0083 144

Shinjuku-ku, Japan
Ep0083 146

Chiba, Japan
Ep0083 147

Kyoto, Japan
Ep0083 148

Adachi-ku, Japan
Ep0083 150

Yokohama, Japan
Ep0083 201

Kuala Lumpur, Malaysia
Ep0083 202

Perai, Malaysia
Ep0083 203

Sungai Buloh, Malaysia
Ep0083 204

Kuching, Malaysia
Ep0083 206

Kuala Terengganu, Malaysia
Ep0083 207

Kota Bharu, Malaysia
Ep0083 208

Pulau Pinang, Malaysia
Ep0083 209

Miri, Malaysia
Ep0083 301

Manila, Philippines
Ep0083 302

Manila, Philippines
Ep0083 303

Cebu City, Philippines
Ep0083 304

Cebu City, Philippines
Ep0083 306

Davao City, Philippines
Ep0083 307

Iloilo City, Philippines
Ep0083 309

Quezon City, Philippines
Ep0083 310

Manila, Philippines
Ep0083 401

Singapore, Singapore
Ep0083 402

Singapore, Singapore
Ep0083 501

Tainan, Taiwan
Ep0083 502

Chiayi City, Taiwan
Ep0083 503

Taichung, Taiwan
Ep0083 504

Taichung, Taiwan
Ep0083 505

Kaohsiung City, Taiwan
Ep0083 601

Khon Kaen, Thailand
Ep0083 602

Bangkok, Thailand
Ep0083 603

Muang, Thailand
Ep0083 605

Bangkok, Thailand
Ep0083 606

Bangkok, Thailand
Ep0083 607

Bangkok, Thailand
Ep0083 608

Muang, Thailand
Ep0083 609

Bangkok, Thailand
Ep0083 901

Chengdu, China
Ep0083 902

Guangzhou, China
Ep0083 904

Zhengzhou, China
Ep0083 905

Beijing, China
Ep0083 906

Beijing, China
Ep0083 907

Changchun, China
Ep0083 908

Lanzhou, China
Ep0083 909

Guangzhou, China
Ep0083 910

Shijiazhuang, China
Ep0083 912

Hangzhou, China
Ep0083 913

Wenzhou, China
Ep0083 916

Yinchuan, China
Ep0083 917

Guangzhou, China
Ep0083 918

Zhanjiang, China
Ep0083 920

Guangzhou, China
Ep0083 921

Nanchang, China
Ep0083 922

Guangzhou, China
Ep0083 923

Zunyi, China
Ep0083 924

Guangzhou, China
Ep0083 925

Suzhou, China
Ep0083 926

Pingxiang, China
Ep0083 927

Xi'an, China
Ep0083 930

Xinxiang, China

Conditions

Explore the condition pages connected to this study.

EPILEPSY PARTIAL SEIZURES WITH OR WITHOUT SECONDARY GENERALIZATION PARTIAL SEIZURES WITH OR WITHOUT SECONDARY GENERALIZATION